The National Science Foundation (NSF) is offering a grant opportunity titled "Biomedical Research Initiative for Next-Gen BioTechnologies - SynBio Control" aimed at accelerating the translation of synthetic and engineering biology advances into early-stage biomedical technologies. This initiative requires proposals that include a two-phased plan: Phase I focuses on proof of principle research, while Phase II involves exploratory research to translate findings into biomedical applications, with NSF supporting Phase I and the National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) supporting Phase II. The total estimated funding for this program is $2.4 million, with an award floor of $300,000 and an expected eight awards to be made. Interested applicants must submit proposals by December 4, 2024, and can reach out to NSF grants.gov support at grantsgovsupport@nsf.gov for assistance.